Published November 1986 | Version v1
Journal article

Follow-up study using iodine-131 metaiodobenzylguanidine imaging in a patient with neuroblastoma

Description

A new radiopharmaceutical, I-131 metaiodobenzylguanidine (I-131 MIBG) was used to determine the location and to follow-up tumors in a 13-month-old girl with neuroblastoma. I-131 MIBG imaging revealed both a primary abdominal tumor and a distant metastatic orbital tumor. Follow-up study with I-131 MIBG imaging demonstrated significant resolution of tumors after external radiotherapy and chemotherapy. I-131 MIBG imaging is a simple, safe, and specific method of determining the location of tumors and also is clinically useful in the evaluation and management of patients with neuroblastoma

Additional details

Publishing Information

Journal Title
Clin. Nucl. Med.
Journal Issue
no.11
Series
Clin. Nucl. Med.
ISSN
0363-9762
CODEN
CNMED